Literature DB >> 21932394

Clinical decision making and research in hepatocellular carcinoma: pivotal role of imaging techniques.

Jordi Bruix1, Maria Reig, Jordi Rimola, Alejandro Forner, Marta Burrel, Ramón Vilana, Carmen Ayuso.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21932394     DOI： 10.1002/hep.24670

Source DB:  PubMed          Journal:  Hepatology        ISSN： 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  22 in total

Review 1.  Recommendations for the use of chemoembolization in patients with hepatocellular carcinoma: Usefulness of scoring system?

Authors:  Xavier Adhoute; Guillaume Penaranda; Paul Castellani; Herve Perrier; Marc Bourliere
Journal:  World J Hepatol       Date:  2015-03-27

2.  Capsule, septum, and T2 hyperintense foci for differentiation between large hepatocellular carcinoma (≥5 cm) and intrahepatic cholangiocarcinoma on gadoxetic acid MRI.

Authors:  Jiyoung Hwang; Young Kon Kim; Ji Hye Min; Seo-Youn Choi; Woo Kyung Jeong; Seong Sook Hong; Hyun-Joo Kim; Soohyun Ahn; Hyeon Seon Ahn
Journal:  Eur Radiol       Date:  2017-05-12       Impact factor: 5.315

Review 3.  Hepatocellular carcinoma in chronic hepatitis C: from bench to bedside.

Authors:  Alessio Aghemo; Massimo Colombo
Journal:  Semin Immunopathol       Date:  2012-07-22       Impact factor: 9.623

Review 4.  Treatment of intermediate-stage hepatocellular carcinoma.

Authors:  Alejandro Forner; Marine Gilabert; Jordi Bruix; Jean-Luc Raoul
Journal:  Nat Rev Clin Oncol       Date:  2014-08-05       Impact factor: 66.675

Review 5.  Transarterial chemoembolization combined with sorafenib for unresectable hepatocellular carcinoma: a systematic review and meta-analysis.

Authors:  Man Yang; Jin-Qiu Yuan; Ming Bai; Guo-Hong Han
Journal:  Mol Biol Rep       Date:  2014-08-05       Impact factor: 2.316

Review 6.  Using Modified RECIST and Alpha-Fetoprotein Levels to Assess Treatment Benefit in Hepatocellular Carcinoma.

Authors:  Jean-Luc Raoul; Joong-Won Park; Yoon-Koo Kang; Richard S Finn; Jun Suk Kim; Winnie Yeo; Blasé N Polite; Yee Chao; Ian Walters; Christine Baudelet; Riccardo Lencioni
Journal:  Liver Cancer       Date:  2014-10       Impact factor: 11.740

Review 7.  Methodological assessment of HCC literature.

Authors:  G Daniele; N Costa; V Lorusso; J Costa-Maia; I Pache; M Pirisi
Journal:  Ann Oncol       Date:  2013-04       Impact factor: 32.976

Review 8.  Usefulness of staging systems and prognostic scores for hepatocellular carcinoma treatments.

Authors:  Xavier Adhoute; Guillaume Penaranda; Jean Luc Raoul; Patrice Le Treut; Emilie Bollon; Jean Hardwigsen; Paul Castellani; Hervé Perrier; Marc Bourlière
Journal:  World J Hepatol       Date:  2016-06-18

9.  Validation of the Liver Imaging Reporting and Data System Treatment Response Criteria After Thermal Ablation for Hepatocellular Carcinoma.

Authors:  Katherine S Cools; Andrew M Moon; Lauren M B Burke; Katrina A McGinty; Paula D Strassle; David A Gerber
Journal:  Liver Transpl       Date:  2019-12-20       Impact factor: 5.799

Review 10.  Locoregional therapies in the era of molecular and immune treatments for hepatocellular carcinoma.

Authors:  Josep M Llovet; Thierry De Baere; Laura Kulik; Philipp K Haber; Tim F Greten; Tim Meyer; Riccardo Lencioni
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2021-01-28       Impact factor: 46.802
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.